Future Science Group期刊
期刊
会议
图书
作者:Francesca Lake
来源:[J].Future Sci. OA, 2018, Vol.4 (1), pp.-Future Science Group
作者:Traci L Carlson , Mehdi Moini , Brian A Eckenrode ...
来源:[J].BioTechniques(IF 2.399), 2018, Vol.64 (4), pp.170-176Future Science Group
摘要:A simple method for extracting protein from human anagen (i.e., actively growing hair stage) head hairs was developed in this study for cases of limited sample availability and/or studies of specific micro-features within a hair. The distinct feature segments of the hair fro...
作者:Andrew E Place , Kelly Goldsmith , Jean-Pierre Bourquin ...
来源:[J].Future Oncol.(IF 3.202), 2018, pp.-Future Science Group
摘要:Venetoclax is a highly selective, potent BCL-2 inhibitor that is approved for some patients previously treated for chronic lymphocytic leukemia, and has shown promising activity in adult studies across several hematologic malignancies. Preclinical studies have demonstrated veneto...
作者:Tian Tian , Linlin Wang , Yan Shen ...
来源:[J].Epigenomics(IF 2.433), 2018, pp.-Future Science Group
摘要:Aim: To investigate the relationship between GRHL3 methylation and the etiology of neural tube defects (NTDs). Materials & methods: Analyze data from a genome-wide DNA methylation array. Targeted DNA methylation analysis was performed for 46 cases and 23 controls. At last, grhl3 ...
作者:Xiaoyu Pan , Desheng Gong , Fei Gao ...
来源:[J].Epigenomics(IF 2.433), 2018, pp.-Future Science Group
摘要:Aim: To examine how enteral feeding affects the intestinal epigenome and gene expression just after preterm birth. Materials & methods: Intestinal tissue from preterm pigs, modeling preterm infants, was collected at birth and 5 days after gradual introduction of infant formu...
作者:Ana Lluch HernÁndez , Cristina Hernando MeliÁ
来源:[J].Future Oncol.(IF 3.202), 2018, Vol.14 (7s), pp.1-3Future Science Group
作者:Adolfo Enrique Diaz , Ruben A Mesa
来源:[J].Future Oncol.(IF 3.202), 2018, Vol.14 (9), pp.797-807Future Science Group
摘要:The treatment landscape for myelofibrosis (MF) has reached the molecular era by targeting different pathways that are implied in this myeloproliferative neoplasm. A few years ago, the first-in-class JAK1/JAK2 inhibitor ruxolitinib, demonstrated reductions in both constitutional s...
作者:Romualdo Barroso-Sousa , Pedro Exman , Sara M Tolaney
来源:[J].Future Oncol.(IF 3.202), 2018, pp.-Future Science Group
摘要:The decision to offer adjuvant therapy to patients with early-stage cancer relies on factors related to the risk of disease recurrence, degree of benefit with the proposed therapy and the associated risk of toxicities. For patients with stages II and III HER2-positive breast canc...
作者:Hampig Raphael Kourie , Ziad Bakouny , Roland Eid ...
来源:[J].Future Oncol.(IF 3.202), 2018, pp.-Future Science Group
摘要:Aim: As no meta-analyses have evaluated tyrosine kinase inhibitors in the adjuvant setting of high-risk renal cell carcinoma (RCC), the aim was to evaluate the benefit of sunitinib and pazopanib in the adjuvant setting. Methods: This meta-analysis included all Phase III rand...
作者:Yuehong Chen , Kun Zou , Jianhong Sun ...
来源:[J].Pharmacogenomics(IF 3.857), 2018, pp.-Future Science Group
摘要:Aim: Performance of a meta-analysis with respect to the genetic predictors of methotrexate (MTX) treatment outcomes, efficacy and toxicity, in patients with juvenile idiopathic arthritis (JIA). Methods: Databases of OVID MEDLINE and OVID EMBASE were searched to collect the s...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×